Home » Authors » P Ken Gillman, MBBS

P Ken Gillman, MBBS

Director, Psychotropical (

Articles

ARTICLES

Atypical Antipsychotics: Where is the Science, Where is the Evidence?

January 1, 2013

P Ken Gillman, MBBS Director, Psychotropical (www.psychotropical.com), Bucasia, Queensland, Australia Dr. Gillman has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Any psychiatrist who has practiced during the last decade has probably written more than a few prescriptions for an atypical antipsychotic. But do these drugs provide any clear advantages over their predecessors?

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound
This comprehensive guide is designed to be a valuable resource for professionals working in...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now